U.S. stock futures traded higher in early pre-market trade, ahead of earnings from Occidental Petroleum Corporation (NYSE: OXY) and Devon Energy Corp (NYSE: DVN). Fed Governor Michelle W. Bowman will speak at 11:10 a.m. ET, while the NY Empire State Manufacturing Index is scheduled to be released at 8:30 a.m. ET.
Futures for the Dow Jones Industrial Average climbed 203 points to 31,600 while the Standard & Poor’s 500 index futures traded rose 19.90 points to 3,951. Futures for the Nasdaq 100 index gained 56.50 points to 13,861.25.
Oil prices traded lower as Brent crude futures fell 1.5% to trade at $58.49 per barrel, while US WTI crude futures fell 1.6% to trade at $52.72 a barrel.
A Peek Into Global Markets
European markets were mostly higher today, with the UK’s FTSE index rising 2.52%, Spanish Ibex Index climbing 1.84%, French CAC 40 Index gaining 1.45%, STOXX Europe 600 Index rising 1.31% and German DAX 30 index inching up 0.42%.
In Asian markets, Japan’s Nikkei Stock Average rose 1.28%, Hong Kong’s Hang Seng Index climbed 1.90%, and China’s Shanghai Composite Index rose 1.43%, while India’s BSE Sensex fell 0.10%.
Analysts at KeyBanc downgraded Glu Mobile (NASDAQ: GLUU) from Overweight to Sector Weight.
Shares of Glu Mobile rose 1.87% to $12.80 in pre-market trading.
G1 Therapeutics Inc (NASDAQ: GTHX) said the FDA had approved COSELA (trilaciclib) for injection to lower the incidence of chemotherapy-induced myelosuppression (damage to bone marrow) in adult patients. G1 Therapeutics plans to begin the post-approval clinical trial in 2022.
Ardagh Group (NYSE: ARD) reported quarterly earnings of 28 cents per share, ahead of the consensus estimate of 26 cents a share.
Freeline Therapeutics Holdings plc (NASDAQ: FRLN) announced the appointment of Michael Parini as its President and Chief Operating Officer.
Plug Power Inc. (NASDAQ: PLUG) announced an agreement to partner with ACCIONA S.A., a global leading supplier of sustainable infrastructure solutions, to serve clients in Spain and Portugal.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.